Lindbrook Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-130
| Closed | -$9.05K | – | 2941 |
|
|
2024
Q3 | $9.05K | Sell |
130
-28
| -18% | -$1.92K | ﹤0.01% | 1724 |
|
|
2024
Q2 | $10.6K | Buy |
158
+39
| +33% | +$2.63K | ﹤0.01% | 1592 |
|
|
2024
Q1 | $8.21K | Hold |
119
| – | – | ﹤0.01% | 1669 |
|
|
2023
Q4 | $7.41K | Buy |
119
+45
| +61% | +$2.52K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $4.15K | Sell |
74
-82
| -53% | -$4.61K | ﹤0.01% | 1845 |
|
|
2023
Q2 | $7.87K | Sell |
156
-4
| -3% | -$213 | ﹤0.01% | 1605 |
|
|
2023
Q1 | $8.73K | Sell |
160
-83
| -34% | -$4.85K | ﹤0.01% | 1527 |
|
|
2022
Q4 | $15.2K | Sell |
243
-90
| -27% | -$5.97K | ﹤0.01% | 1214 |
|
|
2022
Q3 | $23K | Buy |
333
+251
| +306% | +$17.3K | ﹤0.01% | 933 |
|
|
2022
Q2 | $5K | Sell |
82
-7
| -8% | -$384 | ﹤0.01% | 1586 |
|
|
2022
Q1 | $6K | Buy |
89
+45
| +102% | +$2.43K | ﹤0.01% | 1555 |
|
|
2021
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 1844 |
|
|
2021
Q3 | $3K | Hold |
44
| – | – | ﹤0.01% | 1463 |
|
|
2021
Q2 | $3K | Hold |
44
| – | – | ﹤0.01% | 1525 |
|
|
2021
Q1 | $3K | Hold |
44
| – | – | ﹤0.01% | 1481 |
|
|
2020
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 1463 |
|
|
2020
Q2 | $2K | Buy |
+44
| New | +$1.51K | ﹤0.01% | 1464 |
|
Other funds holding AXNX
Lindbrook Capital's AXNX Position: Q4 2024 in Review
Lindbrook Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 130 shares — an estimated $9.05K sold.
Lindbrook Capital first reported a position in AXNX in Q2 2020 and held it in 18 quarters. The position peaked at $23K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- Lindbrook Capital reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Lindbrook Capital sold 130 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $9.05K.
- Lindbrook Capital first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 18 quarters.
- Lindbrook Capital's Axonics, Inc. Common Stock position peaked at $23K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.